Atrás
Rango del Día
$8.84
$9.31
Rango de 52 Semanas
$4.32
$13.71
Volumen
543,662
Promedio 50D / 200D
$9.16
/
$8.69
Cierre Anterior
$8.73
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -2.1 | 0.2 |
| P/B | 1.8 | 3.0 |
| ROE % | -63.6 | 3.6 |
| Net Margin % | -2520.6 | 3.8 |
| Rev Growth 5Y % | -53.1 | 9.9 |
| D/E | 0.1 | 0.2 |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Revenue declined -53.12% annually over 5 years
Debt/Equity of 0.05 — conservative balance sheet
Negative free cash flow of -163.72M
Revenue growth is decelerating — 1Y growth trails 5Y average by 39.71%
Capital efficient — spends only 1.43% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-53.12%
Revenue (1Y)-92.83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-63.62%
ROIC-47.03%
Net Margin-2520.57%
Op. Margin-1905.82%
Seguridad
Debt / Equity
0.05
Current Ratio7.72
Interest Coverage0.00
Valoración
P/E Ratio
-2.05
Forward P/EN/A
P/B Ratio1.79
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -92.83% | Revenue Growth (3Y) | -67.44% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -53.12% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9.68M | Net Income (TTM) | -244.09M |
| ROE | -63.62% | ROA | -74.69% |
| Gross Margin | 61.77% | Operating Margin | -1905.82% |
| Net Margin | -2520.57% | Free Cash Flow (TTM) | -163.72M |
| ROIC | -47.03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.05 | Current Ratio | 7.72 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.05 | Forward P/E | N/A |
| P/B Ratio | 1.79 | P/S Ratio | 51.75 |
| PEG Ratio | -0.02 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -32.67% | ||
| Market Cap | 501.19M | Enterprise Value | 207.51M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9.68M | 135.16M | 91.37M | 53.91M | 200.58M |
| Net Income | -244.09M | -122.31M | -147.03M | -116.95M | 66.98M |
| EPS (Diluted) | -4.53 | -2.27 | -2.76 | -2.47 | 1.38 |
| Gross Profit | 5.98M | 135.16M | 91.37M | 53.91M | 200.58M |
| Operating Income | -184.56M | -154.56M | -191.04M | -131.56M | 71.98M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 326.80M | 547.11M | 696.38M | 758.04M | 609.37M |
| Total Liabilities | 46.33M | 60.18M | 135.02M | 135.99M | 143.32M |
| Shareholders' Equity | 280.47M | 486.93M | 561.37M | 622.04M | 466.04M |
| Total Debt | 13.86M | 10.84M | 11.84M | 6.47M | 12.33M |
| Cash & Equivalents | 307.53M | 471.39M | 618.83M | 710.41M | 579.09M |
| Current Assets | 315.19M | 485.41M | 639.28M | 719.10M | 584.81M |
| Current Liabilities | 40.84M | 48.50M | 56.89M | 50.15M | 33.45M |